Latest filing published 03 Jul 2025 for Cellectar Biosciences, Inc., €21k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Chad J. Kolean is a declared insider of Cellectar Biosciences, Inc., with filings sourced from SEC (Form 4). The record holds 2 filings, for trades running from 8 December 2023 to 2 July 2025.
On the market, this insider has only ever bought: 1 purchase, €21k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant. Since January 2025: 1 purchase and no sales on the market.
Most recently, on 3 July 2025, the filings show an open-market purchase worth €21k in Cellectar Biosciences, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations